By verifying the expression of T cell markers on peripheral blood mononuclear cells (PBMCs) of AML patients and healthy donors, we observed that the expression of PD-1 and TIM-3 was distinctly upregulated on CD8+ T cells of AML patients (Fig. 1b). The gene discussed is CD8A; the disease is acute myeloid leukemia.